US Stock MarketDetailed Quotes
MACK Merrimack Pharmaceuticals
- 14.730
- 0.0000.00%
Close Apr 26 16:00 ET
214.05MMarket Cap-184125P/E (TTM)
14.760High14.710Low55.16KVolume14.720Open14.730Pre Close813.15KTurnover0.59%Turnover RatioLossP/E (Static)14.53MShares15.89052wk High11.42P/B138.55MFloat Cap11.53052wk Low--Dividend TTM9.41MShs Float65.815Historical High--Div YieldTTM0.34%Amplitude1.490Historical Low14.741Avg Price1Lot Size
About Merrimack Pharmaceuticals Company
Merrimack Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. engages in discovering, developing, and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer. Its pipeline includes MM-131, MM-141, and MM-310. The company was founded by Anthony J. Sinskey, Gavin MacBeath, and Ulrik B. Nielsen in 1993 and is headquartered in Cambridge, MA.
Company Profile
SymbolMACK
Company NameMerrimack Pharmaceuticals
Listing DateMar 29, 2012
Issue Price7.00
Founded1993
CEOMr. Gary L. Crocker
MarketNASDAQ
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
AddressOne Broadway,14th Floor
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02142
Phone1-617-720-8606
Company Executives
- Name
- Position
- Salary
- Gary L. Crocker
- Chairman of the Board, President, Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer
- 105.44K
- Noah G. Levy
- Independent Director
- --
- Eric D. Andersen
- Independent Director
- --
- Ana Radeljevic
- Independent Director
- --
- Dr. Ulrik B. Nielsen
- Independent Director
- 102.76K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg